HAMBURG,smsc red dot for hellcat GERMANY / ACCESSWIRE / November 4, 2020 /
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that its management will be presenting at and attending the following upcoming conferences until the end of 2020:
Consilium Strategic Communications 8
th
Annual Healthcare Conference
Date
:
Monday, 16 November 2020
Venue
:
Virtual
Attendee
:
Enno Spillner, Chief Financial Officer
German Equity Forum
Date
:
Monday, 16 November 2020
,
Presentation: 16 November 2020, 2.00 pm (CET)
Venue
:
Virtual
Attendee
:
Dr Werner Lanthaler, Chief Executive Officer
Jefferies London Healthcare Conference
Date
:
Tuesday, 17 November 2020
and Thursday, 19 November 2020
,
Presentation: 19 November 2020, 8.20 am (CET)
Venue
:
Virtual
Attendee
:
Enno Spillner, Chief Financial Officer
Kempen's 17
th
London Conference
Date
:
Tuesday, 24 November 2020
Venue
:
Virtual
Attendee
:
Dr Werner Lanthaler, Chief Executive Officer
Structured FINANCE Digital Week
Date
:
Wednesday, 25 November 2020
Venue
:
Virtual
Attendee
:
Enno Spillner, Chief Financial Officer
18
th
Berenberg European Conference
Date
:
Wednesday, 02 December 2020
,
Presentation: 02 December 2020, 4.00 pm (CET)
Venue:
Virtual
Attendee
:
Dr Werner Lanthaler, Chief Executive Officer
ABOUT EVOTEC SE
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 3,400 employees provide the highest quality stand-alone and integrated drug discovery and development solutions. We cover all activities from target-to-clinic to meet the industry's need for innovation and efficiency in drug discovery and development (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuronal diseases, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases, fibrosis, rare diseases and women's health. On this basis, Evotec has built a broad and deep pipeline of approx. 100 co-owned product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term alliances with partners including Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB and others. For additional information please go to
www.evotec.com
and follow us on Twitter
@Evotec
.
FORWARD-LOOKING STATEMENTS
Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.
IR Contact Evotec SE:
Volker Braun, SVP Head of Global Investor Relations & ESG, Phone: +49.(0)40.56081-775,
Media Contact Evotec SE:
Gabriele Hansen, SVP Head of Global Corporate Communications & Marketing, Phone: +49.(0)40.56081-255,
SOURCE:
Evotec AG via EQS Newswire
View source version on accesswire.com:
https://www.accesswire.com/614415/Evotec-to-Attend-Upcoming-Investor-Conferences
View comments
顶: 9491踩: 3
【smsc red dot for hellcat】Evotec to Attend Upcoming Investor Conferences
人参与 | 时间:2024-09-29 08:18:19
相关文章
- ROCE Insights For Facebook
- DCP Midstream to Participate in Investor Conferences
- To the millions of parents who didn’t choose to homeschool: This is a unique opportunity
- Is The L.S. Starrett Company (SCX) Going to Burn These Hedge Funds?
- HqO Launches Suite of Features to Facilitate Return to Work
- SHAREHOLDER ALERT: PTLA GERN AAN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
- A Magnificent Ascent For The Newest Cloud ETF
- Has Canadian Pacific Railway (CP) Outpaced Other Transportation Stocks This Year?
- Waiting for passengers, American puts Boeing Max in the air
- Biden Holds onto a Winning Margin in the Polls after the 1st Debate
评论专区